Erin Elisabeth Longbrake MD PhD
Neuroimmunology/Multiple Sclerosis
Assistant Professor of Neurology, Yale University
Join to View Full Profile
6 Devine StSte 2BNorth Haven, CT 06473
Phone+1 203-287-6100
Fax+1 203-287-6101
Dr. Longbrake is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Neuroimmunology & Multiple Sclerosis, 2013 - 2016- Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2009 - 2013
Ohio State University College of MedicineClass of 2009
Certifications & Licensure
CT State Medical License 2016 - 2025
MO State Medical License 2013 - 2017
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease. Start of enrollment: 2022 Feb 15
Roles: Principal Investigator
Publications & Presentations
PubMed
- Evaluation of the relationship between brainstem lesions and apnea hypopnea index in patients with multiple sclerosis.Elle Levit, Inessa Cohen, Amit Mahajan, Adam Ulano, Erin E Longbrake
Multiple Sclerosis. 2025-03-29 - Transcriptomic profiling after B-cell depletion reveals central and peripheral immune cell changes in multiple sclerosis.Jessica Wei, Jeonghyeon Moon, Yoshiaki Yasumizu, Le Zhang, Khadir Raddassi
The Journal of Clinical Investigation. 2025-03-11 - 1 citationsMulticenter Automated Central Vein Sign Detection Performs as Well as Manual Assessment for the Diagnosis of Multiple Sclerosis.A R Manning, V Letchuman, M L Martin, E Gombos, T Robert-Fitzgerald
AJNR. American Journal of Neuroradiology. 2025-03-04
Press Mentions
Tiziana Life Sciences Announces Yale University Commences Intranasal Foralumab Dosing in Phase 2 Multiple Sclerosis TrialMarch 25th, 2025- Gut Microbiome Changes Linked to Multiple Sclerosis (MS), New Study FindsFebruary 18th, 2025
- Could Early Treatment Help Delay or Prevent MS in Certain People?April 26th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
